Stratedigm has announced the commercial launch of its A600 High Throughput Auto Sampler (HTAS)
The A600 HTAS shares the same platform-based design philosophy utilised in Stratedigm's existing flow cytometers.
It can be configured as an entry-level model to fit within budgetary constraints while allowing future upgrades with options such as: barcode reader, digital temperature control, and interface to Stratedigm's A700 Hotel, scheduled for launch in 2012.
"The A600 HTAS is Stratedigm's building block in the arena of automation and high-content data acquisition and analysis".
"It has been rapidly adopted by core labs across the nation such as Yale Medical School, Harvard Medical School, and the University of Oklahoma along with private BioTech and Pharma companies during its early access stage, which created significant commercial demand," noted Shervin Javadi, Stratedigm's CEO.
